PMID- 32458348 OWN - NLM STAT- MEDLINE DCOM- 20210715 LR - 20210715 IS - 1573-2576 (Electronic) IS - 0360-3997 (Linking) VI - 43 IP - 5 DP - 2020 Oct TI - Lin28B Regulates Angiotensin II-Mediated Let-7c/miR-99a MicroRNA Formation Consequently Affecting Macrophage Polarization and Allergic Inflammation. PG - 1846-1861 LID - 10.1007/s10753-020-01258-1 [doi] AB - Angiotensin-II (Ang-II) receptor plays a role in allergic airway inflammation; however, the underlying mechanism and role of macrophages need better understanding. In the present study, angiotensin-II infusion (1 mug/kg/min) in ovalbumin-induced airway inflammation mice model significantly decreased immune cell infiltration, goblet cell hyperplasia, and eosinophil numbers in lungs. Ang-II infusion increased M1 and decreased M2 macrophage population in bronchoalveolar lavage fluid and respective macrophage markers in lung macrophages. Similarly, in vitro Ang-II treatment in murine bone marrow-derived macrophages (BMDMs) induced M1 and reduced M2 macrophage phenotype with enhanced bactericidal activity. Mechanistically, Ang-II inhibits Let-7c and miR-99a expression in BMDMs and in vivo as well. Lentiviral overexpression of Let-7c and miR-99a miRNAs in BMDMs abrogated Ang-II-induced M1 phenotype activation and promoted M2 phenotype, which is governed by targeting TNFalpha by miR-99a. In lung macrophages, ovalbumin-induced TNFalpha inhibition was rescued after Ang-II treatment. In BMDMs, knockdown of TNFalpha abrogated Ang-II-induced M2 to M1 macrophage phenotype switch and associated bactericidal activity. Ang-II affects mature miRNA formation by enhancing Lin28B levels in macrophages in vivo and in vitro. Furthermore, Lin28B knockdown prevented Ang-II-mediated inhibition of mature Let-7c/miR-99a miRNA formation, M2 to M1 macrophage phenotype switch, and increased bactericidal activity. Therefore, present study suggests a role of Lin28B in Ang-II-induced Let-7c/miR-99a miRNA formation that consequently affects TNFalpha production, M1 phenotype activation, and allergic airway inflammation. Graphical Abstract Ovalbumin inhibits LIN28B expression thereby fails to inhibit premature to mature Let-7c/miR-99a miRNA formation. Mature miR-99a miRNA that inhibits TNFalpha consequently promotes M2 polarization and allergic airway inflammation. While Ang-II induces Lin28B, which inhibits Let-7c/miR-99a miRNA processing and mature miRNA formation, this results in increased TNFalpha levels that lead to M1 polarization and allergic airway inflammation inhibition. FAU - Jaiswal, Anant AU - Jaiswal A AD - Division of Pharmacology, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, UP, 226031, India. FAU - Maurya, Mohita AU - Maurya M AD - Division of Pharmacology, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, UP, 226031, India. FAU - Maurya, Preeti AU - Maurya P AD - Academy of Scientific and Innovative Research, New Delhi, 110025, India. FAU - Barthwal, Manoj Kumar AU - Barthwal MK AUID- ORCID: 0000-0001-7574-482X AD - Division of Pharmacology, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, UP, 226031, India. manojbarthwal@cdri.res.in. LA - eng PT - Journal Article PL - United States TA - Inflammation JT - Inflammation JID - 7600105 RN - 0 (Lin28b protein, mouse) RN - 0 (MIRNlet-7c microRNA, human) RN - 0 (MicroRNAs) RN - 0 (Mirn99 microRNA, mouse) RN - 0 (RNA-Binding Proteins) RN - 11128-99-7 (Angiotensin II) RN - 9006-59-1 (Ovalbumin) SB - IM MH - Angiotensin II/*toxicity MH - Animals MH - Cell Polarity/drug effects/physiology MH - Cells, Cultured MH - HEK293 Cells MH - Humans MH - Hypersensitivity/immunology/*metabolism MH - Macrophages, Alveolar/drug effects/immunology/*metabolism MH - Mice MH - Mice, Inbred C57BL MH - MicroRNAs/antagonists & inhibitors/*biosynthesis MH - Ovalbumin/toxicity MH - Pneumonia/chemically induced/immunology/metabolism MH - RNA-Binding Proteins/*biosynthesis OTO - NOTNLM OT - Let-7c/miR-99a/TNF OT - Lin28B OT - M1/M2 phenotype OT - allergic inflammation OT - angiotensin-II EDAT- 2020/05/28 06:00 MHDA- 2021/07/16 06:00 CRDT- 2020/05/28 06:00 PHST- 2020/05/28 06:00 [pubmed] PHST- 2021/07/16 06:00 [medline] PHST- 2020/05/28 06:00 [entrez] AID - 10.1007/s10753-020-01258-1 [pii] AID - 10.1007/s10753-020-01258-1 [doi] PST - ppublish SO - Inflammation. 2020 Oct;43(5):1846-1861. doi: 10.1007/s10753-020-01258-1.